1 March 2016 - Since the manufacturer provides no adequate studies, an additional benefit of aflibercept versus the appropriate comparator therapy has not been established.
For more details, go to: https://www.iqwig.de/de/presse/pressemitteilungen/pressemitteilungen/aflibercept-bei-myoper-choroidaler-neovaskularisation-zusatznutzen-nicht-belegt.7193.html?&et_cid=4&et_lid=%25208 [German]